When seizures return in drug-resistant epilepsy: medication review, postoperative recurrence and reassessment

The return of a familiar seizure after a quieter period can be deeply discouraging. The immediate task is safety. The next is to understand the event in the context of the previous seizures and recent changes in treatment or health. Recurrence may reflect incomplete control, interrupted treatment, another illness or an event of a different nature. It should not automatically be taken as proof that every treatment has failed, and unsupervised extra doses or abrupt withdrawal can make assessment harder and less safe. NICE NG217: Diagnosis and assessment of epilepsyNICE NG217: Principles of treatment, safety, monitoring and withdrawal

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Convulsive activity reaching five minutes, repeated seizures without recovery, serious breathing problems or major injury require the emergency response plan. Repeated cluster events can also need urgent treatment even when individual episodes stop. Familiarity with epilepsy is not a reason to assume that every recurrence can be managed by waiting at home. In China, the medical emergency number is 120. NICE NG217: Treating status epilepticus, repeated or cluster seizures, and prolonged seizures CDC: First Aid for Seizures
Original preoperative and postoperative images, operative records, pathology, electrode localization and representative event data can be important. New MRI should be compared with earlier imaging, and video-EEG should seek to characterize current habitual events. A referral note saying postoperative recurrence rarely contains enough information to define a new treatment target. Bernasconi et al.: ILAE structural MRI recommendations and HARNESS protocol, 2019 Tatum et al.: ILAE/IFCN minimum standards for inpatient long-term video-EEG, Epilepsia 2022
The revised plan should identify which medicines continue or change, the next review, the events to record, rescue-treatment instructions and the symptoms requiring emergency care. Every caregiver needs the same current version. Old taper charts or emergency instructions that no longer apply should be clearly identified as superseded. NICE NG217: Principles of treatment, safety, monitoring and withdrawal NICE NG217: Treating status epilepticus, repeated or cluster seizures, and prolonged seizures

Quick answer

The return of a familiar seizure after a quieter period can be deeply discouraging. The immediate task is safety. The next is to understand the event in the context of the previous seizures and recent changes in treatment or health. Recurrence may reflect incomplete control, interrupted treatment, another illness or an event of a different nature. It should not automatically be taken as proof that every treatment has failed, and unsupervised extra doses or abrupt withdrawal can make assessment harder and less safe. NICE NG217: Diagnosis and assessment of epilepsy NICE NG217: Principles of treatment, safety, monitoring and withdrawal

Full guide

The return of a familiar seizure after a quieter period can be deeply discouraging. The immediate task is safety. The next is to understand the event in the context of the previous seizures and recent changes in treatment or health. Recurrence may reflect incomplete control, interrupted treatment, another illness or an event of a different nature. It should not automatically be taken as proof that every treatment has failed, and unsupervised extra doses or abrupt withdrawal can make assessment harder and less safe. NICE NG217: Diagnosis and assessment of epilepsy NICE NG217: Principles of treatment, safety, monitoring and withdrawal

Deal with an ongoing emergency before analyzing its cause

Convulsive activity reaching five minutes, repeated seizures without recovery, serious breathing problems or major injury require the emergency response plan. Repeated cluster events can also need urgent treatment even when individual episodes stop. Familiarity with epilepsy is not a reason to assume that every recurrence can be managed by waiting at home. In China, the medical emergency number is 120. NICE NG217: Treating status epilepticus, repeated or cluster seizures, and prolonged seizures CDC: First Aid for Seizures

Time the event, protect the head and remove nearby hazards. Help the person into a safe side position when possible. Do not restrain the movements, place objects in the mouth or give pills or liquids to someone unable to swallow safely. Use prescribed rescue treatment according to the individualized instructions and training. An extra dose of an ordinary maintenance tablet is not a substitute for a suitable rescue plan.

Compare the current event with the previous pattern

Describe the earliest feature, subsequent behavior, duration, recovery and any injury. A new persistent weakness or prolonged alteration of consciousness should not simply be labeled the old epilepsy. When recording does not interfere with safety, a video can help the clinical team assess an uncertain event. Separate different event types instead of combining all of them into one count. NICE NG217: Diagnosis and assessment of epilepsy Tatum et al.: ILAE/IFCN minimum standards for inpatient long-term video-EEG, Epilepsia 2022

Syncope, sleep-related phenomena, functional seizures and medication effects can resemble aspects of epilepsy, and more than one condition can coexist. A valid epilepsy diagnosis does not establish that every later symptom has the same cause. The purpose of reassessment is to identify what has changed without discarding reliable earlier information.

Build a timeline that the clinician can use

Mark the last definite seizure, the longest interval of control, recent prescription changes, formulation switches, omissions, vomiting, infection and sleep disruption. A close temporal relationship can suggest a possibility but does not prove causation. The clinician needs to compare the actual treatment exposure, event features and relevant findings before deciding which explanation fits. NICE NG217: Principles of treatment, safety, monitoring and withdrawal

If a detail is uncertain, say so. Different caregiver estimates or incomplete observation overnight are useful limitations to document rather than conceal. A short accurate timeline with clearly marked gaps is more informative than a precise-looking count reconstructed from guesses.

Explain missed doses or interrupted supply without embarrassment

Difficulty taking treatment may result from work patterns, cost, cognition, swallowing problems or adverse effects. Those barriers deserve practical attention. If the clinician assumes that every dose was taken as planned, an avoidable interruption can be mistaken for failure of the regimen and lead to unnecessary escalation. Honest information helps identify the right problem. NICE NG217: Principles of treatment, safety, monitoring and withdrawal

What to do after a missed dose depends on the medicine and timing. There is no universal instruction to double the next dose. After a longer interruption, some medicines require a fresh titration assessment; lamotrigine, for example, should not simply be restarted at an old high dose without advice. Contact the prescribing team or pharmacist for instructions appropriate to the actual gap and regimen. DailyMed: Lamotrigine prescribing information, May 2026

Consider new illness and interactions as well as epilepsy itself

Fever, significant dehydration, metabolic disturbances or other acute problems may need assessment and treatment. List medicines recently started or stopped, including temporary prescriptions, nonprescription products and supplements. A change can alter antiseizure drug exposure or produce symptoms that resemble worsening disease. Sleep disruption or stress may be relevant, but they should not be used as an automatic explanation for every recurrence. NICE NG217: Diagnosis and assessment of epilepsy Wu et al.: Clinical practice guidelines for third-generation antiseizure medications, Seizure 2026;134:13–26

Subacute memory or behavioral changes, psychiatric symptoms, persistent frequent seizures or additional neurological abnormalities may prompt evaluation for infection, immune-mediated disease or another cause. Autoimmune encephalitis is not the default diagnosis for all recurrent epilepsy. It requires clinical interpretation of the full presentation, and an isolated antibody finding is not a basis for self-treatment with steroids. Abboud et al.: Autoimmune encephalitis diagnosis and acute management best-practice recommendations, 2021

Return to the agreed plan if recurrence occurs during tapering

If seizures return while medication is being reduced under supervision, contact the responsible team and state exactly which step has been reached. Report the event and recovery. Whether to pause reduction, restore a component or otherwise revise treatment requires an individualized decision. Do not continue the old taper as if nothing happened, and do not independently reinstate every previous medicine at once. NICE NG217: Principles of treatment, safety, monitoring and withdrawal

Safety arrangements may also need revision. A brief quiet period after the event is not automatic clearance for driving, hazardous work or water activities without appropriate supervision. Medical advice and applicable local rules must be considered separately. If these changes affect employment or family duties, ask the clinical team to help explain the necessary adjustments.

Distinguish early postoperative events from late recurrence

An event soon after surgery should be reported promptly. Its interpretation depends on timing, recovery, medication and relevant postoperative findings; a single early seizure does not independently settle the long-term result. Recurrence after a lengthy period of complete control raises a different reassessment of the original disease, treatment extent and possible changes in the seizure network. UCLH: A guide for patients considering epilepsy surgery Petrik et al.: Late seizure recurrence after initial complete seizure freedom following surgery, 2021

A long-term study published in 2021, largely involving structural lesions, identified more than one pattern of late relapse, including events related to the vicinity of the previous target and networks with new clinical features. This does not establish that every recurrence reflects an incomplete first operation. The mechanism in an individual case requires a review of the actual evidence.

Bring the first treatment's records into the new evaluation

Original preoperative and postoperative images, operative records, pathology, electrode localization and representative event data can be important. New MRI should be compared with earlier imaging, and video-EEG should seek to characterize current habitual events. A referral note saying postoperative recurrence rarely contains enough information to define a new treatment target. Bernasconi et al.: ILAE structural MRI recommendations and HARNESS protocol, 2019 Tatum et al.: ILAE/IFCN minimum standards for inpatient long-term video-EEG, Epilepsia 2022

Selected patients may need functional imaging or further invasive recordings, but recurrence does not mean that every previous investigation must be repeated automatically. Ask which findings remain reliable, which need updating and how the proposed new test could change the options. Expanding invasive sampling is useful only when it addresses a reasonable localization question. Traub-Weidinger et al.: EANM PET and SPECT practice guideline for epilepsy, 2024 The value of additional electrodes when stereo-electroencephalography is inconclusive, Epilepsia 2024

Repeat surgery is an option for selected patients

A Chinese retrospective study published in 2025 reported that some patients achieved favorable outcomes after repeat epilepsy surgery, while surgical complications also occurred. Its small, selected sample cannot guarantee benefit or safety for another patient. A new decision requires renewed localization, functional assessment and an explicit comparison of the expected benefit with the additional risk. Hu et al.: Factors associated with outcome after repeat epilepsy surgery, retrospective study, 2025

Previous treatment may already have changed anatomy and functional capacity. Ask why the proposed target now differs, which seizures it is intended to improve and what new deficits are possible. Alternatives should also be discussed if further removal is not acceptable. An incomplete first result does not force a choice between immediate reoperation and abandoning treatment altogether.

Disease-specific repeat-treatment evidence has limits

A study published in August 2026 examined single and repeated epilepsy operations in children with tuberous sclerosis complex. Recurrence could relate to a previously targeted focus or another focus becoming apparent, and some children benefited from further surgery. This was retrospective evidence in a particular cause of epilepsy, not a universal probability for repeated operations in all drug-resistant patients. Valdrighi et al.: Single and repeat epilepsy surgery in pediatric TSC, retrospective study, August 2026

The findings help explain why some causes require continuing assessment of the wider disease rather than attention only to the tissue already treated. Etiology-specific therapy, monitoring of other affected organs and genetic counseling may also belong in the plan. Those decisions should be coordinated with the relevant specialists. Krey et al.: Current practice in diagnostic genetic testing of the epilepsies, ILAE Genetics Commission, 2022

Check device care when seizures increase after stimulation

For a patient with an implanted stimulator, document changes in relation to recent programming, battery alerts, device checks and medication adjustments. The specialist team can assess hardware, settings and clinical response. An adequate battery does not prove that the current program is optimal, and increased seizures do not necessarily mean that the system is broken. NINDS: Deep Brain Stimulation 中华医学会：神经调控治疗癫痫临床指南2026版，中华医学杂志106(11)，期刊目录及摘要

Do not use instructions from an unqualified source to change settings, or assume that an unfamiliar service can manage every device. Carry the implant card and recent programming records when traveling. For care across borders, establish whether the service at home supports the exact system and whether the teams need to exchange technical and clinical information.

Give functional events their own diagnosis and treatment plan

The AAN functional seizure guideline published in December 2025 emphasizes clinical history, event characteristics and appropriate testing, together with assessment for coexisting epilepsy. Functional symptoms are real, not deliberate performance. A normal scalp EEG alone also cannot establish that all events are functional. Clear explanation matters as much as avoiding unnecessary treatment. AAN: Management of Functional Seizures, clinical guideline summary, December 2025

If some new events are confirmed to be functional seizures, repeatedly escalating antiseizure medication for those events may not help. Necessary treatment for coexisting epilepsy should continue according to the clinical plan. Ask the team to explain how each event type is recognized and managed, rather than leaving caregivers to improvise decisions about which episodes need attention.

Include the emotional impact in follow-up

Recurrence can make a patient feel that earlier progress has been erased. Yet prior reductions in seizures, injuries avoided and activities regained remain meaningful. The new problem can be addressed through safety measures, a review of causes and a revised treatment plan. Psychological or psychiatric support may be helpful alongside neurological care, particularly when depression or severe fear interferes with daily life. Mula et al.: Drug-treatment changes, depression and quality of life in adult drug-resistant focal epilepsy, Epilepsia July 2026

Caregivers can assist with observations and appointments without substituting blame for investigation. Medication effects, sleep, mood and epilepsy may interact, and accusations rarely clarify the mechanism. Thoughts of self-harm, marked behavioral disturbance or severe depression deserve prompt professional attention rather than being dismissed as an understandable reaction that must simply be endured.

Stabilize locally before arranging reassessment in China

Someone with ongoing prolonged events, impaired consciousness or acute neurological symptoms should receive emergency evaluation where they are. Traveling to a preferred Chinese hospital should not delay stabilization. Once clinically stable, submit the event timeline and previous investigation and procedure records so that the receiving center can advise whether an outpatient review, monitoring admission or multidisciplinary assessment is appropriate. CDC Yellow Book 2026: Travelers with Chronic Illnesses 中国抗癫痫协会官方网站及CAAE癫痫地图入口

Arrange continuity of medication, any necessary accompaniment and communication between the two services. Having paid for a journey does not make an invasive treatment medically necessary. If no new safely treatable target is identified, request an updated medication, device or supportive-care plan that can be carried out after the return home.

Leave with instructions for the next change

The revised plan should identify which medicines continue or change, the next review, the events to record, rescue-treatment instructions and the symptoms requiring emergency care. Every caregiver needs the same current version. Old taper charts or emergency instructions that no longer apply should be clearly identified as superseded. NICE NG217: Principles of treatment, safety, monitoring and withdrawal NICE NG217: Treating status epilepticus, repeated or cluster seizures, and prolonged seizures

Reassessment after recurrence aims to find modifiable factors and choose a reasonable next pathway. It respects the information already established while allowing new evidence to change the interpretation. Knowing what to observe, whom to contact and which decision comes next makes a distressing return of symptoms a more manageable clinical problem. Jehi et al.: Timing of referral for epilepsy surgery evaluation, ILAE consensus, 2022